Literature DB >> 21526840

Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery.

Kirill A Veselkov1, Lisa K Vingara, Perrine Masson, Steven L Robinette, Elizabeth Want, Jia V Li, Richard H Barton, Claire Boursier-Neyret, Bernard Walther, Timothy M Ebbels, István Pelczer, Elaine Holmes, John C Lindon, Jeremy K Nicholson.   

Abstract

Ultra-performance liquid chromatography coupled to mass spectrometry (UPLC/MS) has been used increasingly for measuring changes of low molecular weight metabolites in biofluids/tissues in response to biological challenges such as drug toxicity and disease processes. Typically samples show high variability in concentration, and the derived metabolic profiles have a heteroscedastic noise structure characterized by increasing variance as a function of increased signal intensity. These sources of experimental and instrumental noise substantially complicate information recovery when statistical tools are used. We apply and compare several preprocessing procedures and introduce a statistical error model to account for these bioanalytical complexities. In particular, the use of total intensity, median fold change, locally weighted scatter plot smoothing, and quantile normalizations to reduce extraneous variance induced by sample dilution were compared. We demonstrate that the UPLC/MS peak intensities of urine samples should respond linearly to variable sample dilution across the intensity range. While all four studied normalization methods performed reasonably well in reducing dilution-induced variation of urine samples in the absence of biological variation, the median fold change normalization is least compromised by the biologically relevant changes in mixture components and is thus preferable. Additionally, the application of a subsequent log-based transformation was successful in stabilizing the variance with respect to peak intensity, confirming the predominant influence of multiplicative noise in peak intensities from UPLC/MS-derived metabolic profile data sets. We demonstrate that variance-stabilizing transformation and normalization are critical preprocessing steps that can benefit greatly metabolic information recovery from such data sets when widely applied chemometric methods are used.

Entities:  

Mesh:

Year:  2011        PMID: 21526840     DOI: 10.1021/ac201065j

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  75 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 2.  Metabolomics: A Primer.

Authors:  Xiaojing Liu; Jason W Locasale
Journal:  Trends Biochem Sci       Date:  2017-02-11       Impact factor: 13.807

Review 3.  A global approach to analysis and interpretation of metabolic data for plant natural product discovery.

Authors:  Manhoi Hur; Alexis Ann Campbell; Marcia Almeida-de-Macedo; Ling Li; Nick Ransom; Adarsh Jose; Matt Crispin; Basil J Nikolau; Eve Syrkin Wurtele
Journal:  Nat Prod Rep       Date:  2013-04       Impact factor: 13.423

4.  Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines.

Authors:  Leslie P Silva; Philip L Lorenzi; Preeti Purwaha; Valeda Yong; David H Hawke; John N Weinstein
Journal:  Anal Chem       Date:  2013-10-02       Impact factor: 6.986

5.  Untargeted metabolomics profiling and hemoglobin normalization for archived newborn dried blood spots from a refrigerated biorepository.

Authors:  Miao Yu; Georgia Dolios; Vladimir Yong-Gonzalez; Olle Björkqvist; Elena Colicino; Jonas Halfvarson; Lauren Petrick
Journal:  J Pharm Biomed Anal       Date:  2020-08-23       Impact factor: 3.935

Review 6.  Mass Spectrometry: A Guide for the Clinician.

Authors:  Munirah Alsaleh; Thomas A Barbera; Ross H Andrews; Paiboon Sithithaworn; Narong Khuntikeo; Watcharin Loilome; Puangrat Yongvanit; Isobel J Cox; Richard R A Syms; Elaine Holmes; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2019-05-09

7.  Chemo-informatic strategy for imaging mass spectrometry-based hyperspectral profiling of lipid signatures in colorectal cancer.

Authors:  Kirill A Veselkov; Reza Mirnezami; Nicole Strittmatter; Robert D Goldin; James Kinross; Abigail V M Speller; Tigran Abramov; Emrys A Jones; Ara Darzi; Elaine Holmes; Jeremy K Nicholson; Zoltan Takats
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-07       Impact factor: 11.205

8.  Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease.

Authors:  Xijun Wang; Aihua Zhang; Ying Han; Ping Wang; Hui Sun; Gaochen Song; Tianwei Dong; Ye Yuan; Xiaoxia Yuan; Miao Zhang; Ning Xie; He Zhang; Hui Dong; Wei Dong
Journal:  Mol Cell Proteomics       Date:  2012-04-13       Impact factor: 5.911

9.  Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism.

Authors:  Adam D Kennedy; Marcus J Miller; Kirk Beebe; Jacob E Wulff; Anne M Evans; Luke A D Miller; V Reid Sutton; Qin Sun; Sarah H Elsea
Journal:  Genet Test Mol Biomarkers       Date:  2016-07-22

10.  Microbial-mammalian cometabolites dominate the age-associated urinary metabolic phenotype in Taiwanese and American populations.

Authors:  Jonathan R Swann; Konstantina Spagou; Matthew Lewis; Jeremy K Nicholson; Dana A Glei; Teresa E Seeman; Christopher L Coe; Noreen Goldman; Carol D Ryff; Maxine Weinstein; Elaine Holmes
Journal:  J Proteome Res       Date:  2013-06-24       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.